Inovio Pharmaceuticals Inc vs JD.Com Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while JD.Com Inc trades at $31.43 (market cap $44.04B). The key difference: JD.Com Inc is far larger — about 560.7× Inovio Pharmaceuticals Inc's market cap, and JD.Com Inc pays a 3.13% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | JD | |
|---|---|---|
Market Cap | $78.55M | $44.04B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $36.17 |
52-Week Low | $0.66 | $25.19 |
Enterprise Value | $49.56M | $30.10B |
Dividend Yield | — | 3.13% |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →